Vineti

Vineti was an enterprise software company for cell and gene therapy supply chain management, headquartered in San Francisco and founded in 2016. Its Personalized Therapy Management (PTM) platform — sold as PTM Enterprise and PTM Essentials — orchestrated the patient-centric supply chain behind autologous and allogeneic cell therapies, gene therapies and personalized cancer vaccines: chain of identity, chain of custody, apheresis and manufacturing scheduling, clinical-site workflows, and regulatory reporting. PTM was delivered as a configurable aPaaS on AWS, with HIPAA compliance certified by Avertium and GAMP-aligned validation. Vineti was named a World Economic Forum Technology Pioneer and raised a $35M Series C in 2020. The PTM software was acquired by Johnson & Johnson in 2023 to continue supporting its commercial therapy rollouts and clinical trials, and Vineti ceased to operate as an independent company: vineti.com no longer resolves and the domain now sits on Johnson & Johnson name servers. This profile is retained as a historical record — there is no live API surface to catalog.

Vineti is profiled on the APIs.io network. Tagged areas include Company, Cell and Gene Therapy, Life Sciences, Supply Chain, and Healthcare.

4.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyCell and Gene TherapyLife SciencesSupply ChainHealthcareClinical TrialsPharmaceuticalEnterprise SoftwareDefunct

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 4.8/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 0.0 / 17
Operational Transparency 0.6 / 11
Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/vineti: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Build 1

SDKs, sample code, and the tooling you integrate with

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: vineti
name: Vineti
description: 'Vineti was an enterprise software company for cell and gene therapy supply chain management, headquartered in
  San Francisco and founded in 2016. Its Personalized Therapy Management (PTM) platform — sold as PTM Enterprise and PTM Essentials
  — orchestrated the patient-centric supply chain behind autologous and allogeneic cell therapies, gene therapies and personalized
  cancer vaccines: chain of identity, chain of custody, apheresis and manufacturing scheduling, clinical-site workflows, and
  regulatory reporting. PTM was delivered as a configurable aPaaS on AWS, with HIPAA compliance certified by Avertium and
  GAMP-aligned validation. Vineti was named a World Economic Forum Technology Pioneer and raised a $35M Series C in 2020.
  The PTM software was acquired by Johnson & Johnson in 2023 to continue supporting its commercial therapy rollouts and clinical
  trials, and Vineti ceased to operate as an independent company: vineti.com no longer resolves and the domain now sits on
  Johnson & Johnson name servers. This profile is retained as a historical record — there is no live API surface to catalog.'
url: https://raw.githubusercontent.com/api-evangelist/vineti/refs/heads/main/apis.yml
image: https://web.archive.org/web/2023id_/https://vineti.com/wp-content/uploads/2021/05/cropped-Vineti_Favicon-1-192x192.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
x-status: defunct
specificationVersion: '0.20'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Cell and Gene Therapy
- Life Sciences
- Supply Chain
- Healthcare
- Clinical Trials
- Pharmaceutical
- Enterprise Software
- Defunct
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://forgeglobal.com/vineti_stock/
- type: GitHubOrganization
  url: https://github.com/vinetiworks
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 0
  pass: local-v1
x-coverage:
  state: none
  reason: defunct
  detail: Vineti's PTM software was acquired by Johnson & Johnson in 2023 and the company no longer operates — vineti.com
    has no A record at all (its name servers are now ns01-04.jnjdns.com), every subdomain probed (api., app., docs., developer.,
    portal., status.) is NXDOMAIN, and the last Wayback capture of the site is 2023-04-07, so there is no host left to run
    contract discovery against.
  evidence:
  - url: https://vineti.com/
    status: 0
  - url: https://api.vineti.com/openapi.json
    status: 0
  - url: https://vineti.com/.well-known/agent-card.json
    status: 0
  - url: https://web.archive.org/web/20230407042038/https://vineti.com/
    status: 200
  - url: https://github.com/vinetiworks
    status: 200
  checked: '2026-08-05'